AnaptysBio Inc buy Guggenheim
Start price
10.03.25
/
50%
€15.30
Target price
10.03.26
-
Performance (%)
153.59%
Price
11.12.25
€38.80
Summary
This prediction is currently active. The BUY prediction by Guggenheim for AnaptysBio Inc has seen massive gains of 153.59%. This prediction currently runs until 10.03.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 2.646% | 2.646% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat